Placement Completed
Actinogen Medical placement
A$17m raised
Announced 2 Feb 2026 · ASX: ACW
Advisers
Actinogen Medical
Issuer
Not disclosed
Lead managers
- Lead manager
- Issuer
- Actinogen Medical
- Completed
- 9 Feb 2026
- Sector
- Biotech and pharmaceuticals
Similar deals
- Recce Pharmaceuticals entitlement offer Jun 2025 · A$15.8m · Biotech and pharmaceuticals
- Arovella Therapeutics placement Feb 2025 · A$15m · Biotech and pharmaceuticals
- Imugene equity raising Mar 2026 · A$20m · Biotech and pharmaceuticals
- Nyrada placement Sep 2026 · A$14m · Biotech and pharmaceuticals
- Paradigm Biopharmaceuticals placement Apr 2026 · A$14m · Biotech and pharmaceuticals
Sources
- 2 Feb 2026 ACW secures funding beyond XanaMIA AD trial final results ASX
- 9 Feb 2026 Application for quotation of securities - ACW ASX